EIT Health Accelerator · THE EIT HEALTH ACCELERATOR ... impact on both the pharmaceutical industry and patients to tackle challenges set by top pharma partners. ive challenges have

EIT Health AcceleratorAccelerator CatalogueEIT Health invites entrepreneurs, start-ups and SMEs to submit applications to participate in the EIT Health Accelerator programmes.

EIT Health Accelerator Catalogue 2019 Invitation to Participate in Accelerator Programmes

1

Table of Contents

Table of Contents TABLE OF CONTENTS .................................................................................................................................................................... 1 THE EIT HEALTH ACCELERATOR ................................................................................................................................................. 2

1.1 ACTIVITY SUMMARY ............................................................................................................................................................................... 3 1.2 EIT HEALTH ACCELERATOR CONTACTS; BUSINESS CREATION MANAGERS ........................................................................................ 9 1.3 EIT HEALTH EXPECTATIONS, ELIGIBILITY AND REGIONAL DISTRIBUTION ......................................................................................... 10

HOW TO JOIN ACTIVITIES IN THE INCUBATE! ACTIVITY LINE ............................................................................................ 12 1.4 EIT HEALTH BOOTCAMPS ................................................................................................................................................................... 12 1.5 BOOTCAMP PLUS: HEALTH VENTURE LAB ......................................................................................................................................... 21 1.6 START-UP MEETS PHARMA (2019 EDITION) .................................................................................................................................... 22 1.7 CAIXAIMPULSE .................................................................................................................................................................................... 24

HOW TO JOIN ACTIVITIES IN THE VALIDATE! ACTIVITY LINE ............................................................................................ 27 1.8 LIVING LABS AND TEST BEDS .............................................................................................................................................................. 27 1.9 MENTORING AND COACHING NETWORK ........................................................................................................................................... 28 1.10 HEADSTART ......................................................................................................................................................................................... 29 1.11 EUROPEAN MARKET ACCESS FOR PARTNERS (EMAPS) (RUN BY CAMPUS PILLAR) ....................................................................... 32

HOW TO JOIN ACTIVITIES IN THE SCALE! ACTIVITY LINE ................................................................................................... 34 1.12 EUROPEAN BRIDGEHEAD PROGRAMME ............................................................................................................................................. 34 1.13 EUROPEAN HEALTH CATAPULT .......................................................................................................................................................... 35 1.14 INVESTOR NETWORK .......................................................................................................................................................................... 39 1.15 GOGLOBAL.......................................................................................................................................................................................... 40 1.16 GOLD TRACK ....................................................................................................................................................................................... 49

ANNEX: ........................................................................................................................................................................................ 51 SUSTAINABILITY VISION ................................................................................................................................................................................... 51 UNDERSTANDING TRL .................................................................................................................................................................................... 51 UNDERSTANDING HIR .................................................................................................................................................................................... 54


2

The EIT Health Accelerator

The EIT Health Accelerator creates an ecosystem where innovation can thrive. It gathers the best and brightest health entrepreneurs and provides them with the support, skills and services they need to get their ideas off the ground and into the market. In the INCUBATE! activity line entrepreneurial training and support activities, we help entrepreneurs create a business plan out of an initial business idea. These programmes vary in length from two to twelve months and offer entrepreneurs an international perspective and the opportunity to build their network with leading health organisations. The VALIDATE! activity line helps start-ups and entrepreneurs to continuously improve their ventures with access to suitable Living Labs and Test Beds, mentoring and coaching expertise within the community, and to gain an understanding of local/regional regulatory and reimbursement schemes. The SCALE! activity line focuses on developing tools and networks that can provide financing for projects and smaller SMEs, as well as facilitating access to potential investors including angel networks, corporate financers and crowd funders. Furthermore, internationalisation programmes support European start-ups and scale-ups in the domain of Medtech, Biotech and Digital Health so that they can expand within Europe, the United States, Korea, China, Japan, and Canada. This business creation supply chain supports the acceleration of innovation projects and access to relevant facilities for start-ups and SMEs throughout the consortium. The Accelerator is open to applications from all entrepreneurs, start-ups, scaleups, and SMEs in Europe. If you have no previous connection to any EIT Health partners or CLC representatives, introduce yourself – a list of partners can be found at eithealth.eu/partners, or you can contact the Business Creation Managers at regional CLCs at eithealth.eu/clc. Some applications may encourage reference letters from EIT Health partners or regional CLCs as supplements to support the application. For more support submitting an application please visit our Help for Applicants page https://www.eithealth.eu/help-for-applicants.

about:blank

http://eithealth.eu/clc

https://www.eithealth.eu/help-for-applicants


3

1.1 Activity Summary The table below includes a short summary of the EIT Health Accelerator programmes: The INCUBATE! activity line supports future entrepreneurs or scientists looking to develop start-ups or receive innovation training and assistance. These include activities such as the EIT Health Bootcamp programmes that help entrepreneurs develop and validate their business idea.

EIT Health Bootcamps: 5 Programmes offered in 2019! Who can apply: Post-docs, Master’s students, graduates, scientists, doctors and other

professionals working on ideas in Medtech, Biotech, Digital Health, HealthTech, scalable eHealth and diagnostics.

Applicants: All over Europe Deadline: Application Wave 1: 11th January to 13th March

Application Wave 2: 8th April to 17th June Register: Through the EIT Health Optimy platform. Please note that not all Bootcamp

applications will be considered during both application waves.

A Summary of the 5 Bootcamp Programmes:

CRAASH @ Barcelona is a 12-week programme that helps European research teams (of up to three participants) launch successful device, diagnostic and Digital Health innovations that improve health and patient care. Teams move research to market through onsite and online mentoring with experts from Europe and CIMIT (Boston)– the most experienced health accelerator in the world). 1 st wave application. Contact: Judit Pérez Valero ([email protected]) Validation Lab @Delft is a unique two-month pressure cooker that allows aspiring entrepreneurs from all over Europe to discover the business potential of their Medtech ideas. The programme helps participants to explore and validate their ideas, market potential and business model – and to launch in markets all over Europe. 2nd wave application. Contact: Tjarda Voorneman ([email protected])

https://eithealth.optimytool.com/en/


mailto:[email protected]


4

Medtech Bootcamp @Erlangen is open to European early-phase start-up teams with ideas in MedTech and Digital Health. The interdisciplinary focus of the Central Institute of Medical Engineering (ZiMT/FAU) and its broad network of health industry experts, healthcare practitioners, and digitalisation research groups will allow the Medtech Bootcamp to provide focused support and matchmaking alongside the EIT Health Mentoring and Coaching Network (MCN). 2nd wave application. Contact: Heike Leutheuser ([email protected]) Digital Health Validator @Dublin is a two-month Digital Health incubator hosted in Trinity College Dublin – Europe’s highest-ranked university for producing entrepreneurs (Pitchbook, 2018). The programme empowers Digital Health entrepreneurs to validate the technology and market potential of their early-stage business. 1 st wave application. Contact: Breandán Goss ([email protected]) E-Boat Bootcamp is an accelerator for start-ups with innovative mobile health solutions. It is a unique programme consisting of a distance learning module and a Hackathon Cruise in the Baltic region to validate, develop and launch products in the European market. E-Boat drives change and transforms health services with mobile health solutions (m-solutions). 1 st wave application. Contact: Joanna Baranowski ([email protected])

Additional Incubate Programmes, focused on ideation:

Bootcamp Plus: Health Venture Lab is an intensive, healthcare-focused accelerator that helps aspiring individuals and teams advance their innovative ventures through an extended period of coaching and training. 1 st wave application. Who can apply: Master’s students, graduates, scientists and young professionals. Region: All over Europe, main programme offered in Budapest, satellite programmes

are offered in Lodz (Poland) and Debrecen (Hungary) Contact: Daniel Szemerey ([email protected]) Deadline: 13th March CaixaImpulse is an intensive acceleration programme that runs over a period of 18 months for the creation of new products and companies in the health and life sciences sector. This programme is designed to start the translation of health research projects into a market-ready product. Who can apply: Project Leaders must be legally responsible for the project and have tertiary

qualifications (e.g. university graduates, professors or doctors) Region: Spain Deadline: 13th March Contact: Belen Perat ([email protected]) Register: www.convocatoriaslacaixa.org/Convocatorias/login.iface?idioma=3





http://www.convocatoriaslacaixa.org/Convocatorias/login.iface?idioma=3


5

2019 Start-ups Meets Pharma challenges teams of graduate students, post-docs and

professionals to develop innovative chronic care solutions that go “beyond the pill”, with support from key pharma partners in Europe. This programme invites start-ups that are developing digital solutions with an impact on both the pharmaceutical industry and patients to tackle challenges set by top pharma partners. Five challenges have been released in collaboration with Amgen, Bayer Ferrer, Johnson & Johnson, and UCB Biosciences.

Who can apply: Project Leaders must be legally responsible for the project and have tertiary qualifications (e.g. university graduates, professors or doctors)

Region: Applicants from all over Europe are welcome, main programme will be offered in Heidelberg and Mannheim (Germany), roadshows in Germany, Spain, UK, Belgium

Deadline: 27th March Contact: Matteo Consonni ([email protected]) Register: Through the EIT Health Optimy platform, starting from 11th January

The VALIDATE! activity line places emphasis on validating products and services. Our network of Living Labs and Test Beds provides entrepreneurs with the means to test products throughout the value chain. Other activities allow entrepreneurs to gain understanding in local and regional regulatory and reimbursement schemes and provide access to market experts.

Living Labs and Test Beds offers entrepreneurs access to the services of a network of living labs and/or test beds, which can support the innovation process throughout the different phases of the value chain (ideation, co-creation, validation and scale-up). The final goal is to enhance the conception of fully market-ready products with high added value and a high probability of success. Who can apply: Registered European start-ups and SMEs that want to test and improve their

product Deadline: 27th February, Additional cut-offs available approximately every 2 months Website: https://www.eithealth.eu/accelerator/livinglabs Contact: Cecilia Vera ([email protected]); Giuseppe Fico ([email protected]) Mentoring and Coaching Network gathers subject matter experts and top-of-the-line mentors from all over Europe to help address the specific needs of start-ups in Medtech, Biotech and Digital Health. Who can apply: Experts willing to mentor and entrepreneurs seeking mentorship Deadline: Ongoing Contact: Jagadeesh Gandla ([email protected])



about:blank


6

EU Health MAPS (run by the Campus pillar) is an innovative platform which supports entrepreneurs and innovators to navigate the complex processes and pathways involved in accessing healthcare markets across Europe. Among others, the activity provides specific knowledge about the finance and reimbursement schemes of different European countries. Who can apply: Start-ups interested in gaining transparency on the innovation process Deadline: Ongoing Contact: Tracey Marriot ([email protected]) Laura Suhlrie, start-up contact ([email protected]) The European BRIDGEHEAD Programme allows European start-ups and scale-ups individualised internationalisation support. It provides entrepreneurs who are active in the health domain support for soft-landings and facilitates their cross-border mobility and market entry beyond the home market. It also offers mentoring, resources, office space and other services to start-ups that need them. Who can apply: Incorporated start-ups interested in soft-landings all over Europe Deadline: 27th February Contact: Aina Pascual ([email protected]) Anna Badurska ([email protected]) Register: Through the EIT Health Optimy platform Headstart offers funding and support to emerging companies and SMEs aiming to develop new products and services and thereby shorten time to market. The purpose of the programme is to accelerate market entry and create new economic activity. The maximum funding granted is €50,000. Who can apply: Start-ups and SMEs from all over Europe, with regional selection Deadline: 27th March. Some CLCs may have second calls Contact: Your local Business Creation Manager, please see contact Register: Through the EIT Health Optimy platform

SCALE! activities focus on more mature start-ups and SMEs and facilitate access to tools and networks for financing and market expansion. The European Health Catapult programme prepares promising ventures for investment by offering individualised mentoring and refreshing pitching skills. Our internationalisation programmes, like GoGlobal, support European ventures so that they can expand beyond Europe’s borders to China, Korea, Japan and Canada. The Investor Network and the Crowdfunding Platform round out the Accelerator portfolio.

European Health Catapult is an individualized training programme that boosts the development and publicity of top-notch European health start-ups. The programme exposes Biotech, Medtech and Digital Health start-ups to high-quality experts, health industry leaders and international investors through intensive and multi-channel involvement of the whole EIT Health community. The programme is organised as a competition, with the finalists pitching at our Annual Summit.

about:blank






http://eithealth.eu/wp-content/uploads/2015/03/Catapult-brochure-online.pdf


7

Who can apply: Already incorporated micro- and small enterprises (<50 employees), spin-offs from all over the EIT Health community that are active in the fields of Medtech, Biotech and Digital Health, operating in an EU Country. Participants should also be available to travel to the semi-finals taking place in different cities of Europe (San Sebastian for Medtech, London for Digital Health, Delft for Biotech) in November as well as to the EIT Health Summit in Paris in December 2019 for the finals

Deadline: 27th March Contact: Anna Badurska ([email protected]) Register: Through the EIT Health Optimy platform Investor Network addresses the issue of early-to-late-development stage fundraising across Europe to conquer health markets faster and more effectively. This is a European network which connects health-oriented investors and promising start-ups through cross-border financing and co-investments, making it the first pan-European, EU-driven network solely focused on financing health innovation. Who can apply: Start-ups seeking funding from €500k to more than €30M Deadline: Ongoing, with quarterly cut-off dates for evaluation Contact: Caroline Saï ([email protected]) GoGlobal provides companies with the competence needed for growth and international expansion. It consists of four complementary programmes addressing different regions. Medtech, Biotech and Digital Health programmes are available. Possible destinations include Japan, China and Canada. Who can apply:Mature start-ups or SMEs with the ambition to expand their international market reach Deadline: 27th March Contact: GoGlobal Canada programme Olivier Fontaine ([email protected]) GoGlobal Medtech/Digital Health Olof Berfglund ([email protected]) Start.Smart.Global (Japan and Korea) Stephanie Wehnelt ([email protected]) Medtech Xchange Benajmin Stöcklein ([email protected]) Register: Through the EIT Health Optimy platform




about:blank

mailto:[email protected])




8

Gold Track is an acceleration programme for high-potential health start-ups and SMEs to become global players. It aims to pair these ventures with high-profile influencers that set strategic goals following an individualised connection approach. Account managers then offer support by monitoring your progress and opening networks. Who can apply: Mature start-ups or SMEs with the ambition to become global leaders

Applications require nomination Deadline: Application start date to be announced in early spring Contact: Joy Cürten ([email protected]) Register: Through the EIT Health Optimy platform

Crowdfunding platform is the first European cross-border crowdfunding platform specifically aimed at more mature healthcare start-ups and SMEs. Applying start-ups undergo a comprehensive selection process. Who can apply: Mature start-ups or SMEs searching for equity of at least €500k Deadline: On a rolling basis Contact: Jörg Trinkwalter ([email protected]) Register: http://beta.aescuvest.eu/




http://beta.aescuvest.eu/


9

1.2 EIT Health Accelerator Contacts; Business Creation Managers To support you on your business creation journey, a strong international team is ready to assist you in identifying the right programme. Applications for Country/Region Business Creation Manager Email

Germany and Switzerland Matteo Consonni [email protected]

France Anais Delicourt Ipshita Singh

[email protected] [email protected]

Belgium and The Netherlands Bart Haex [email protected]

UK and Ireland Rosemary Gallagher [email protected]

Scandinavia Christos Vaitsis [email protected]

Spain Irene Sánchez [email protected]

Innostars Regions see Regional Section for details Nuno Viegas [email protected]

The EIT Health HQ Office is also available to support you in your journey through the EIT Health Accelerator. Questions about the overall strategic, procedural, evaluation, technical and granting inquiries can be directed to the following individuals:

Role Name Email Director of Business Creation, HQ

Kurt Höller

[email protected]

Business Creation Manager, HQ

Joy Cürten

[email protected]

Business Creation Manager, HQ Laura Suhlrie [email protected]

Business Creation Project Manager, HQ Salvatore Demelas [email protected]

Programme Manager – Mentoring and Coaching Network, Living Labs & Test Beds Jagadeesh Gandla [email protected]

Programme Manager – Bridgehead Aina Pascual [email protected]
















10

1.3 EIT Health Expectations, Eligibility and Regional Distribution Expectations The Accelerator is open to applications from all entrepreneurs, start-ups, scaleups, and SMEs in Europe. If an applicant has no previous connection to any EIT Health partners or CLCs, they are invited to introduce themselves: a list of partners can be found at eithealth.eu/partners, or contact the Business Creation Managers at regional CLCs (see eithealth.eu/clc). Some applications may encourage reference letters from EIT Health partners or regional CLCs as supplements to support the application. We ask for all entrepreneurs and teams to commit to participating fully in any EIT Health programme. If full participation and commitment cannot be guaranteed an agreement must be made in advance with the activity lead. Regional applications accepted from across Europe Entrepreneurs are typically distributed across our seven regional offices in the following manner:

● Germany / Switzerland (also recommended for Austrian companies) ● France ● Spain ● Belgium / The Netherlands (also recommended for Israeli companies) ● UK / Ireland (also recommended for Welsh companies) ● Scandinavia (Sweden, Denmark, Estonia) ● EIT Health InnoStars (see below)

Innostars countries include Croatia, Hungary, Italy, Poland, and Portugal. Further countries might be included in the near future. They will also accept countries from the RIS-Region which currently include: Czech Republic, Greece, Lithuania, Slovakia, Malta, Bulgaria, Cyprus and Romania. Each year more countries are added. Applicants from Austria are encouraged to contact the Germany/Switzerland node. Applicants from Israel are encouraged to contact the Belgium/Netherlands node. Applicants from Norway, Finland, Estonia are encouraged to contact the Scandinavian node. Applicants from other EU Countries not listed are encouraged to contact the Innostars node.

Funding EIT Health can award a maximum of €50,000 in grants per start-up per year. This maximum refers to grants awarded as part of Headstart, prize money distributed within an EIT Health Accelerator programme, and reimbursements for travel and accommodation when invited to participate at an EIT Health event. This maximum does not include the commercial value of an activity. Promotion and Branding Start-ups supported by EIT Health agree to the EIT Health branding. Start-ups participating in Accelerator activities agree to use the “Accelerated by EIT Health” logo and display it in their

about:blank

http://eithealth.eu/clc


11

partnership page. Start-ups agree to mention EIT Health in its press releases as a partner whenever appropriate. EIT Health supports start-ups participating in EIT Health programmes by helping to promote their success stories on the EIT Health webpage. To mark special achievements, EIT Health is willing to support by sharing the start-ups' social media posts, publishing interviews or writing other related articles on a case-by-case basis. Sustainability vision Since 2016, the EIT Health Accelerator has offered its programmes as complimentary based on structured selection processes to determine company valuation and merit. It does not ask for any contribution in return. In order to continue to support start-ups and the European economy, in the future EIT Health may ask awarding companies to contribute commitment fees or share in the companies’ economic success. If EIT Health makes amendments to its current complimentary structure, participating companies will be informed in a timely manner and prior to signature.


12

How to join activities in the INCUBATE! Activity Line

In the INCUBATE! Activity Line, innovation training and support activities like Validation Lab and other Bootcamp programmes help entrepreneurs to create a business plan out of an initial business idea within a two-month programme. Furthermore, local training activities are organised to augment existing programmes at CLCs, with a focus on key skills in the healthcare sector.

1.4 EIT Health Bootcamps In 2019, five Bootcamps and one Bootcamp Plus programme will provide intensive incubation programmes over a period of 2-3 months (some might be up to 6 months). The programmes are suitable for European teams that have the ambition to become entrepreneurs and explore the opportunities of their health business idea. The programmes help them to design and validate their business model and discover its market potential, competition, USPs and target customers. The Bootcamp programmes target teams of MSc, MDs and PhD students and/or Postdocs, and professionals who have a business idea for a product still in the research and development stage. The programme only enlists teams (2 to 4 members, depending on the bootcamp). The commercial value of these programmes is an estimated €15,000 and no equity is asked for in return. What we ask from teams: ● Teams of 2 to 4 people depending on the bootcamp; ● Ambition, drive and commitment to fulfil a dream and build a leading company around an

innovative idea with a potentially scalable business model; ● Attendance at all sessions and workshops for the duration of the Bootcamp; ● Willingness to interview at least 100 stakeholders about a business idea; ● The ideal team profile features a combination of skills, such as business-lead and product-

development-lead; ● Selection of teams is based on the quality of the business idea, their fit for the programme

and the team’s motivation and level of commitment. Important dates: Applications will be accepted in two waves:

➢ Wave 1: 11th January to 13th March

➢ Wave 2: 8th April to 17th June Selection procedure: ● Applications will open via the EIT Health application platform, hosted by Optimy. ● To apply, you will need to create an EIT Health Optimy account: eithealth.optimytool.com. ● After review, you may receive an invitation to pitch your business idea via Skype.

http://eithealth.optimytool.com/


13

● A selection committee will choose the most promising start-ups to participate in the programmes. The committee will include diverse experts from each Bootcamp.

● Applicants may only attend one Bootcamp, but can apply to more than one. ● Applicants must commit to the programme attendance expectations.

What we offer: If chosen for an EIT Health Bootcamp, applicants will receive training with a commercial value equivalent to approximately €15,000. Additionally, each programme includes financial grants to support in travel and other associated costs incurred during the programme. The programme will also support funding for a field trip – an opportunity to pitch your idea across Europe. The funding is allocated by the specific Bootcamp. However, the funding is not intended to be all-inclusive. Generally, a Bootcamp accepts 10 to 15 teams (2-3 team members) within one programme.

A. EIT Health Bootcamp: CRAASH Barcelona

➢ Submission Deadline: First Wave, 13th March Pitch CRAASH Barcelona is a 12-week programme over a period of six months designed to help European Healthtech research teams launch successful device, diagnostic and Digital Health innovations that improve health and patient care. Project teams move from research to market through mentoring with experts from Europe, and from CIMIT in Boston, USA – the most experienced health business accelerator in the world. CRAASH Barcelona is an EIT Health Bootcamp organised by Biocat in collaboration with EIT Health and CIMIT. Is it for me? CRAASH accepts teams in the health-tech and medical technology sector, including:● Diagnostics ● Devices ● Digital Health projects for disease analysis or detection ● Delivery of health and healthcare ● Digital Health solutions within mobile health (mHealth) ● Electronic Health Records (I) ● Health information technology (IT) ● Wearable devices ● Telehealth and telemedicine ● Big data ● Social media ● Personalised medicine


14

Research projects that will not be accepted include drug development projects that specialise in developing compounds that deliver or improve the delivery of medicines to targeted areas in the body. CRAASH supports research projects and soon-to-be incorporated or already incorporated start-ups at a minimum development stage of TRL 3 or TRL 4, and with a proof of concept or proof of feasibility. If already incorporated they must: 1) be looking for an application in healthcare for their technology and/or 2) be researching/validating their business model. Important dates

● Application deadline: 13th March ● Start of programme: 13-15 April, 2019 ● Final week: First week of November, 2019 ● After successful completion of the full programme, teams will travel to the CIMIT

The Journey This 12-week training programme (over a period of six months) will include on-site and off-site sessions in both Barcelona and Boston. Eight teams will have a kick-off week in Barcelona, after which they will be coached over a period of two months via eight webinars held every Tuesday from 16:00-18:00 CET. After the webinars, selected teams will visit other countries to validate their business concept in partner organisations in France (Medicen), The Netherlands (Yes!Delft), and the participants successfully fulfilling all the programme milestones will travel to Boston in cooperation with CIMIT. The Programme CRAASH Barcelona is a 12-week programme over a period of six months that helps European Healthtech research teams launch successful device, diagnostic and Digital Health innovations that improve health and patient care. Project teams move from research to market through mentoring with both European and US experts from CIMIT in Boston – the most experienced health business accelerator in the world. CRAASH Barcelona is an EIT Health Bootcamp organised by Biocat in collaboration with EIT Health and CIMIT. The programme is divided into three main phases: Phase I: CRAASH Barcelona (Biocat and CIMIT) During this phase, teams validate their problem-solution and solution-market fit, specifically for the Healthtech market. The programme takes teams out of their comfort zone to conduct discovery interviews. Each team is assigned an experienced executive: successful healthcare entrepreneurs, commercialisation experts and investors that provide one-to-one facilitation throughout the programme. Teams interact each week with this panel of EU and Boston-based experts by presenting and defending findings, attending lectures,


15

and completing readings. Teams receive feedback to help balance their decision risks. Phase II: European Market Validation (Medicen Paris and Yes!Delft) Selected teams will join for two different three-day road trips to investigate the market potential in France (Medicen Paris) and Holland (Yes!Delft), validate clinical need and verify appropriate regulatory pathways and reimbursement methods. Phase III: Boston Close Out Teams successfully completing all the program milestones will travel to Boston to pitch their deck in front of the CIMIT ecosystem and will also extend their trip to validate the market. This will be an opportunity for teams to meet different stakeholders that will help them validate or pivot the strategy defined during CRAASH Barcelona, while exploring collaborations and building their first network in Boston. Additional Application Points CRAASH Barcelona teams must consist of three members:

● Entrepreneurial Lead: focusing on overall business objectives, customer definition, business plan, etc., and responsible for coordinating the team’s work. Does not need to have a business background.

● Clinical Lead: focusing on medical and healthcare delivery issues. ● Technical Lead: focusing on available technology options, requirements and

architectural issues. Note: If your current team is missing any of these three profiles please contact the activity leader Contact information: Activity Leader: Judit Pérez ([email protected]) Second contact point: Raquel Riera ([email protected]) In cooperation with:

B. EIT Health Bootcamp: Validation Lab

➢ Last possible Submission: Second Wave, 17 June, 2019 Pitch Validation Lab is a unique two-month programme with intensive elements that allows aspiring entrepreneurs from all over Europe to discover the business potential of their Medtech ideas.

about:blank



16

The programme helps participants to explore and validate their ideas, market potential and business model – and to launch in markets all over Europe. Is it for me? This programme is open to masters students, graduates, scientists and medical professionals with a Medtech idea (hardware or with complex technology) and the ambition to start (if they have not done so already) a company and become entrepreneurs. Important dates: ● Application deadline: 17 June, 2019 ● Kick-off programme and mentor matching: 26 August, 2019 ● Launch day and final presentations: 29 October, 2019

The Journey After the first weeks of the programme, the teams will go on a two-week road trip through Europe (Denmark, Belgium and Spain) to learn more about healthcare systems and explore markets in other countries. During the road trip, teams will validate their mature assumptions about their businesses in markets in other European countries as well. After the road trip, a final event will take place where the teams will be connected to investors, launching customers etc. The final result will be gaining a solid foundation for their product’s market fit, and a validated business plan. The Programme: Validation Lab takes off in The Netherlands, Delft. For the first five weeks (2-3 days a week), you will be part of the YES!Delft tech incubator. This part also includes fieldtrips throughout the Netherlands. After a break of one week, teams will leave for a 2 weeks road trip through Germany, Denmark and Spain. The last week we close at Delft. With over 12 years of experience in building tomorrow’s leading firms, YES!Delft provides you with a proven successful programme. Two days per week are filled with workshops, Peer2Peer coaching, mentoring, expert talks, excursions to hospitals, and networking. We provide you with the right tools to validate the commercial feasibility of your idea. Each week you will test assumptions about your business model by talking to as many experts, potential customers and other stakeholders as possible. For the remaining days of the week, we open up our networks, challenge you to get out of the building and talk to as many stakeholders as possible. Contact Information: Activity Leader: Tjarda Voorneman ([email protected]) Second contact point: Noor Figdor ([email protected]) In cooperation with:

about:blank

about:blank


17

C. EIT Health Bootcamp: Medtech Bootcamp

Last possible Submission: Second Wave, 17 June, 2019 The Pitch The EIT HEALTH BOOTCAMP: Medtech Bootcamp aims to efficiently equip interdisciplinary teams of ambitious engineers and health practitioners with an individually tailored entrepreneurial toolkit, a convincing business plan and a strong network of investors. Participants will be prepared to catapult their promising healthcare transforming ideas from sketch to market. Is It for me? The programme is aimed at teams of MSc, MDs, PhD students and/or Postdocs, professionals who have a business idea for a product still in research and development. Specifically, it targets technology readiness level (TRL) from around 2 (technology concept formulated) to level 5 (technology validated in a relevant environment). Important dates: ● Application deadline: 17 June, 2019 ● Start of programme: 2 September, 2019 ● Final week: To be determined (approx. October/November)

The Journey: In this eight-week programme, the first month will focus on training. The first phase will take place at the start-up forge at UnternehmerTUM, based in Munich and at the FAU and ZiMT in Erlangen. This phase will focus on validation, which is the key to a successful start-up and business idea. After a two weeks break, the teams will participate in a roadshow, travelling to Coimbra (Instituto Pedro Nunes), Paris (Medicen Paris Region), Barcelona (IESE Business School), and Lodz (Uniwersytet Medyczny w Lodzi).

Programme:

Throughout the Medtech Bootcamp, meticulously selected teams will transform their start-up ideas in medical technology into successful start-ups within an eight-week programme on business creation and validation. The teams start in Munich at UnternehmerTUM where teams


18

will be provided with a business design toolkit to develop and implement a sustainable future business plan. They will then create prototypes by applying proven methods from design and management. At the FAU in Erlangen, teams will focus on validation through specific training in intellectual property, licensing, and medical product legislation. They will have access to testbeds and living labs as well as a broad clinical network provided by the entrepreneurial landscape of the Medical Valley. Through selective matchmaking, teams will be in close contact with healthcare experts and future customers to improve the design and feasibility of their concepts. The teams will then tour Europe during the third phase to pitch their start-up ideas to possible investors, learn market specifics, and challenge their value proposition at roadshow stops.

Contact information:

Activity Leader: Heike Leutheuser ([email protected]) Second contact point: Philipp Dumbach ([email protected])

In cooperation with:

D. EIT Health Bootcamp: E-Boat Bootcamp

➢ Last Possible Submission: First Wave, 13 March, 2019 The Pitch E-Boat is an accelerator for start-ups with innovative mobile health solutions. It is a unique programme consisting of six weeks’ distance learning and two weeks of a Cruise Hackathon Formula in the Baltic region to validate, develop and launch products in the European market. E-Boat drives change and transforms health services with m-solutions. Is it for me? The programmes are aimed to support incorporated start-ups with mHealth solutions. The technology should be ready to be demonstrated and to validate the mobile-friendly product/service and business concept with an English language version. Important dates: ● Application deadline: 13 March, 2019

about:blank



19

● Start of programme: 12 June, 2019 ● Final week: likely in November, Dublin

The Journey Apart from the distance learning module of 6 weeks, the programme offers two weeks of Cruise Hackathon with five stops:

• Stockholm (RISE) • Gdansk (Gdansk Medical University) • Klaipeda (Kaunas University of Technology) • Riga (Riga Stradins University) • Tallinn (University of Tartu)

The Programme: Do you want to validate your mobile-friendly product or service and business concept? Do you want to discover new paths for health through mobile technologies and launch solutions in markets all over Europe? E-Boat provides the practical tools and business development opportunities for start-ups focused on creating mHealth apps and solutions to enhance self-care and self-management. The programme is divided into two phases. Phase 1: The first phase offers six weeks of a Distance Learning Module, with online training on the Principles of Universal Design, Lean methodology and customer development tools. Phase 2: The Cruise Hackathon Formula includes two weeks of an intensive and unique business creation sea-trip. Start-ups will validate and pitch their ideas in five Baltic Sea destinations: Stockholm, Gdansk, Klaipeda, Riga and Tallinn. In this diverse and stimulating cruise environment, start-ups will develop solutions with the support of IT and universal design experts. During the cruise, start-ups will learn, develop their products, identify customers, and meet potential clients and local investors – all under the supervision of IT specialists and universal design mentors. Contact information: Activity Leader: Joanna Baranowska ([email protected]) Second contact point: Ewa Nocun ([email protected])





20

E. EIT Health Bootcamp: Digital Health Validator

➢ Last Possible Submission: First wave, 13 March, 2019 The Pitch The Digital Health Validator empowers Digital Health entrepreneurs to validate the technology and market potential of their early stage business. Each applying team will participate in a two-day problem-solution fit session. Fifteen teams will be selected to participate in a Bootcamp based in Trinity to validate product-market fit and revenue model. The Bootcamp immerses teams in the powerful start-up ecosystem and matches them with a mentor. This programme will include a road trip to bring an international context. Is it for me? Digital Health start-ups are encouraged to apply, particularly in the two focus areas of bringing care home and value from clinical data. Connected health and health tech ideas are also welcome. The technology can be early-stage, but must be beyond just the idea stage so that technological viability and market can be validated. The product solution should be scalable with the potential to be successfully marketed globally, not just in Europe. We seek start-ups with the passion to create a new healthcare future. Health is being disrupted from the outside in, and current availability of technological building blocks offer a unique potential for revolutionary innovation in health and wellness. Factors including converging technologies, cost of entry, regulatory and market drivers are all accelerating change, and enabling patients to take control of their own health. Important project dates: ● Application deadline: 13 March, 2019 ● Start of programme: 18 May, 2019 in Dublin ● Final week: 11 July, 2019

The Journey The programme will start at the Trinity Business School in Dublin on 18 May and will run for eight weeks. In the final two weeks of the programme, participants will engage in a customer validation road trip to allow them to investigate market potential. The locations include Grenoble (School of Management), Newcastle University, Madrid (Universidad Politecnica de Madrid) and others.


21

The Programme: The Digital Health Validator is an eight-week high-intensity Bootcamp that allows 15 start-ups in Digital Health to road-test and validate their hypotheses with the help and guidance of a number of healthcare and start-up experts in Dublin. Run by Europe’s number one university for producing entrepreneurs (PitchBook 2018), Validator will make use of Trinity’s existing network in the start-up ecosystem, bringing in successful CEOs and founders in the field of Digital Health to share their wisdom and learnings. Guests will also speak about the challenges they have faced and how they overcame them. Moreover, the staff at Trinity’s Innovation and Entrepreneurship Hub, Trinity’s key interface with entrepreneurial activities, will be heavily involved in the planning and running of the Validator programme. Using our years of experience in delivering award-winning innovation and entrepreneurship training and running start-up accelerators, we can guarantee the successful start-ups a transformational experience that will benefit both the personal development of each entrepreneur, as well as the growth and development of the start-up. Contact information: Activity Leader: Breandán Goss ([email protected]) In cooperation with:

1.5 Bootcamp Plus: Health Venture Lab ➢ Last Possible Submission: First wave, 13 March, 2019

The Pitch: Health Venture Lab Bootcamp is an intensive, healthcare-focused accelerator that helps aspiring individuals and teams advance their innovative ventures through an extended period of coaching and training. It provides academic, business and industrial expertise to ensure that participants have a unique opportunity to improve all aspects of their businesses. Participants have the chance to build a strong international network by becoming a member of a Europe-encompassing start-up community.

Important Dates

● 24-26 April: Launch Days ● April-October: Each month's last Wednesday - Friday Training ● 17-19 October: Demo Days


22

Is it for me? The programme targets international teams from EIT Health and Regional Integration Scheme countries, who are solving a healthcare-related problem and have already built at least an initial prototype. Our High School Partnership programme allows teams from three partnering high schools to participate. These will require a lower barrier to entry (no need for prototype), and so participate on fewer occasions. The Programme The programme will offer a six-month-long acceleration for candidates with an entrepreneurial mindset who want to develop their personal and team business competencies and explore and develop their health-related business ideas. HVL Budapest offers weekly training sessions, coaching and a Europe-wide network (EIT Health and RIS), through which start-ups can reach out to crucial partners. Each monthly workshop consists of a teaching session with thematic presentations on hard-to-attain knowledge, including Regulations in the Healthcare Sector, Health Data Protection and Early-Stage Financing. These are provided by our expert coaches and through intensive one-on-one coaching sessions with business coaches experienced in building a company. Participants will acquire the knowledge, skills and attitude necessary to develop the strategic, organisational, networking and financial basis of a growth-oriented firm. Contact information: Activity Leader: Daniel Szemerey ([email protected]) Second contact point: Andrea Bagoly ([email protected]) In cooperation with:

1.6 Start-up Meets Pharma (2019 Edition) ➢ Last possible submission: 27 March, 2019

The Pitch The 2019 EIT Health start-ups Meet Pharma is a challenge-based programme connecting teams of MSc, MDs PhD students, as well as post-docs and professionals, developing innovative solutions for chronic care beyond the pill with key pharma partners in Europe. The programme invites start-ups developing digital solutions, which impact both the Pharma industry and patients, to tackle set challenges in collaboration with top pharma partners. In 2019, the following five Challenges have been released in collaboration with Amgen, Bayer, Ferrer,




23

Johnson & Johnson, and UCB Biosciences (please check the document attached to this page for extensive information about the challenges and the programme). Important Project Dates

• Start of the programme and Module 1: 6 June to 14 June • Module 2: 24 June to 28 June • Module 3: 8 July to 17 July • End of the programme and Module 4: 25 July to 26 July

Is it for me? The programme is open to dedicated teams of at least two team members with the ambition, drive and commitment to fulfil a dream and build a leading company around an innovative idea with a potentially scalable business model. The ideal team profile features a combination of skills, such as business-lead and product-development-lead. Selection of teams is based on the quality of the business idea, their fit for the selected challenge and the team’s motivation and level of commitment. Programme: The programme consists of the following 4 Modules:

• Module 1: 4 days of workshops on innovation, corporate ventures, business development, and start-up collaborations by C-level experts from four leading pharma partners (Location: Heidelberg/Mannheim)

• Module 2: 5 days of beyond-the-pill tailored trainings on business modelling, marketing and sales strategy, financial planning and forecasting, regulatory hurdles and pitching & presenting skills. (Location: Heidelberg/Mannheim)

• Module 3: Roadshows to pharma partners in 4 different leading innovation areas in Europe with presentations, feedback & interaction with BD teams for possible collaboration and deal generation. (different locations)

• Module 4: Demo day with industry partners and Investors Network (VCs and BA Network). (Location: Heidelberg/Mannheim)

The following challenges are addressed in the programme:

• Rheumatoid Arthritis: providing the right diagnosis at the right point in time. Partners: Amgen Tech Hub; Amgen Amgevita Brand. Area: Chronic Inflammatory disease; Rheumatoid Arthritis.

• Telemedicine based patient support program. Partner: Bayer AG Area: Women’s Health, Cardiology, Oncology, Hematology, Ophthalmology, Pulmonology.

• Parkinson’s Disease – How to improve the management of “wearing-off” motor episodes (dyskinesias, dystonias); including freezing episodes.


24

Partner: Ferrer. Area: Parkinson’s Disease.

• Creating a Biomarker Measurement Platform. Partners: Johnson & Johnson World Without Disease. Area: Disease agnostic but focusing on Disease Prevention and Interception with positive and negative prediction models.

• The measurement of skin health in the assessment of treatment efficacy and ability to predict flares for conditions such as Atopic Dermatitis and Chronic Spontaneous Urticaria currently relies on direct clinical observation which can be subject to variability and subjectivity. Partners: UCB, Immunology Patient Value Units and Translational Medicine Departments. Area: Atopic Dermatitis and Chronic Spontaneous Urticaria.

Contact information: Activity Contact: Matteo Consonni ([email protected]) In cooperation with:

1.7 CaixaImpulse ➢ Last possible submission: 18 March, 2019

The Pitch CaixaImpulse is an intensive 18-month acceleration programme for the creation of new products and ventures in the health and life sciences sector. This programme is meant to jump-start the translation of health research projects into a market-ready product.

mailto:[email protected])


25

Important dates:

● Call opens: 4 February, 2019 ● Application deadline: 18 March, 2019 ● Start of programme: July 2019 in Barcelona ● Four Weeks of Training: between July and November 2019

Is it for me? The programme targets project leaders from all European countries that research in the health and life sciences sector. CI-V is aimed and the following requirements apply:

• Project Leaders must be legally responsible for the project and have tertiary qualifications (university graduates, professor or doctor).

• Incorporated companies cannot apply. Programme: CaixaImpulse will award 25 projects to create a develop a valorisation plan and have access to experts and investors to generate new business opportunities. The programme will assist projects in completing a commercialisation plan to validate their strategy and attract private investment. EIT Heath's support will allow the expansion of the programme to other European countries, which will allow the internationalisation of the activities. Contact information: Activity Leader: Belén Perat ([email protected]) Second contact point: Pablo Martinéz ([email protected]), Alexandre Esteban([email protected])

about:blank

about:blank



26



27

How to join activities in the VALIDATE! Activity Line

The VALIDATE! activity line start-ups and entrepreneurs with a variety of programmes related to validation activities. Entrepreneurs can use suitable living labs and test beds to support them in validation-related aspects during different phases of the value chain. The Mentoring and Coaching Network provides expertise within the European community and beyond. The EU Health Maps programme (run by the Campus pillar) provides access to specific knowledge, such as data biorepositories and analysis techniques, or understanding of local/regional regulatory and reimbursement schemes. The Bridgehead programme offers start-ups access to an infrastructure of Catalysers, Accelerators and Incubators all over Europe to assess the local market.

1.8 Living Labs and Test Beds ➢ Several application dates apply: Please find the following application deadline on the

website

The Pitch This programme offers entrepreneurs the services of a network of living labs and test beds, which support the innovation process throughout the different phases of the value chain (ideation, co creation, validation and scale-up). The final goal is to enhance the conception of fully market ready products with high added value and a high probability of success. Important Project Dates: We have established several cut-off dates for application throughout the year:

● February 27th ● Other cut off dates, approximately every 2 months, will be announced in February.

Is it for me? The programme is open to any European start-up, SME, entrepreneur and innovation project that aims to improve their product by validating, co-creating and ideating with the end-user in a real environment. All organisations seeking to test or improve their products are invited to work with the EIT Health living labs Network. It has a wide geographic coverage throughout Europe and wide coverage of thematic areas such as Medtech, Digital Health or e-health, allowing a diverse group of organisations to benefit from the network across Europe. The Programme: The Living Labs and Test Bed programme to accelerate start-ups and SMEs was launched in 2018, and has four phases:

https://www.eithealth.eu/accelerator/livinglabs


28

1. Annual call (six cut-off dates, bimonthly) Annually, start-ups and SMEs from Europe can request access to the services of the European network of living labs and test beds focused on the healthcare domain, and the EIT Health living labs network.

2. Analysis of applications and needs A group of experts from the project consortium analyses applications, performs a needs analysis, and selects according to the applicant’s needs. This is to ascertain which are the most suitable living labs or test beds to help them.

3. Matchmaking and contact This phase exists to agree, define and organise the specific service to be provided.

4. Follow up Both the living lab or test bed and the start-up will be monitored by a living lab expert, who is responsible for the project network to accompany the process. They will gather information to evaluate the proper functioning of the programme and make any necessary improvements.

Contact information: Operational EIT Health Contact: Jagadeesh Gandla ([email protected]) Activity Leader and Content Contact: Cecilia Vera Muñoz ([email protected]) Partner Contact: Hervé Michel ([email protected]) In cooperation with:

1.9 Mentoring and Coaching Network ➢ Applications for this programme are ongoing

The Pitch Now the expertise of the EIT Health network can be accessed on-demand. The Mentoring and Coaching Network (MCN) gathers subject matter experts and top-of-the-line mentors from all over Europe to help with the specific needs of start-ups in Medtech, Biotech and Digital Health. Important Project Dates Entrepreneurs may register on an ongoing basis and begin the matching process to find an expert. Start-ups that apply via the Optimy application platform and are evaluated positively may be selected to receive a small stipend to cover a portion of fees of your chosen expert. If you are





29

interested in accessing the Mentoring and Coaching Network as one of these start-ups, please speak to the Business Creation Manager at your CLC and the programme manager listed above. Is it for me? The programme is aimed at all business maturity levels, ranging from start-ups developing their product to more mature scale-ups with a developed product and in the phase of expanding to new markets. The Programme To create a vast pool of MCN experts, EIT Health has integrated its individual experts, partners, institutions and corporations into one robust, curated platform of quality mentors, coaches and subject-matter experts with specific know-how and relevant track records from around the EU. Contact information EIT Health Programme Manager: Jagadeesh Gandla ([email protected])

In cooperation with the EIT Health Community

1.10 Headstart ➢ Last possible submission: 27 March, 2019. Some regions may offer second cut-off dates.

The Pitch The EIT Health Headstart Programme provides funding of up to €50,000 for companies and SMEs to develop new products and services. Selected companies will work on their product launch project with support from the regional managers to access local and EIT Health networks. Companies should be seeking to develop projects that fit the overall EIT Health objective: “Healthy Living, Active Ageing, Improved Health Care,” Additional more specific focus areas identified by EIT Health for 2019 include:

● Towards holistic care pathways ● Creating the enabling environment for healthcare transformation ● Harnessing the power of real-world data (RWD) ● Bringing care home ● From the workplace to the health place: employer leadership in improving health ● Fostering healthy lives by introducing behavioural change



30

Purpose of Programme The purpose of the EIT Health Headstart Funding Programme is to:

● support the applicants in realising next steps towards market and shorten time-to-market for innovative products and services

● verify the need/benefit of the product/service for users/customers/payers/partners ● increase the possibility of attracting further private investment

Timeline Application opens: 11 January, 2019 Submission deadline: 27 March, 2019. Second cut-off date may apply. Regional selection specifics:

● Belgian/Netherlands CLC Applicants: second cut-off date in September ● German/Swiss CLC Applicants: second cut-off date in September ● Scandinavian CLC Applicants: Written feedback from evaluators will only be provided

anonymously and upon request. ● Spanish CLC Applicants: Grant up to €40,000 for their selected start-ups. Winners of the grant

will be invited to pitch their project plan to a jury panel and compete for an additional €10,000 grant at the end of the year.

● French CLC Applicants: Grant up to €40,000 for their selected start-ups. Winners of the grant will be invited to pitch their project plan to a jury panel and compete for an additional €10,000 grant at the end of the year.

● UK/Ireland CLC Applicants: No additional directions for applicants in this node. ● Innostars CLC Applicants: No additional directions for applicants in this node.

Project grant agreement signatures: Dependent on selection, expected June-September 2019 Grant attribution (total budget): Dependent on selection, expected August-October 2019 Intermediate report: required before 31 December, 2019 Final report: Required at the end of the project Application Support Applicants are strongly encouraged to seek advice and contact their regional EIT Health Business Creation Manager (BCM) for guidance before submitting an application. The regional BCMs can be found in the Support Contacts section. They may be able to offer support to the project owner in producing an application which fits the scope and goals of the EIT Health Headstart Funding Programme. All Headstart applications will require a confirmation letter to establish that the company has an existing relationship with the EIT Health network. Please see the Eligibility Criteria for details. Is it for me? Eligible applicants and projects A company must be incorporated/registered to apply.


31

The EIT Health Headstart Funding Programme is suitable for micro and small enterprises (according to the EU SME definition) spin-offs, and start-ups that have a well-developed prototype and are ready to launch a product. In rare circumstances, not-yet-incorporated companies may apply however, they must be incorporated upon selection. Ideal applicants have an estimated company valuation of less than €1m. Applicants above this valuation are more suitable for SCALE! programmes.

The Application

● Must be in English. ● Submitted through the EIT Health Optimy Registration platform. Incomplete submissions,

late submissions, or submissions via any other routes (e.g. email) will not be accepted. Register your EIT Health account and apply here: https://eithealth.optimytool.com/en/

● Additional information may be attached to the application. This may include graphs or video links (maximum three minutes’ duration in English language or with English subtitles). Please be aware that the reviewers may not consider these attachments as a basis for their evaluation.

● An existing relationship between the start-up and EIT Health must be established before the application submission. Therefore, applications must be accompanied by a letter confirming this relationship. This letter must be provided by an EIT Health partner or the CLC BCM from the region the applicant is applying to. The letter serves to confirm a relationship to the EIT Health network and does not constitute endorsement or serve as a certification of validity/eligibility. Please consult your regional BCM to discuss this point if no previous relationship exists through an EIT Health partner. All EIT Health Partners by region can be found here.

The Project

● The project or product must be within the scope of the main challenges in EIT Health: Healthy Living, Active Ageing, and Improved Healthcare.

● The applicant(s) or company must own or have rights to the intellectual property that is the basis for the project or product (if applicable).

● The project or product has to be at least at TRL 4

Eligibility ● Applications should only be submitted to one EIT Health region. ● Applications should only be submitted to the region the applicant self-identifies with. EIT

Health regional distribution information can be found in section 1.3. ● The Regional Director and EIT Health Headquarters (KIC LE) are entitled to have the final

decision in any disputes. ● Applicants are only allowed to participate in one of the following programmes, either EHC or

Headstart Programme.

The Funding A maximum EIT Health contribution of €50,000 can be requested by each start-up or SME.

http://ec.europa.eu/growth/smes/business-friendly-environment/sme-definition_en


https://www.eithealth.eu/partners


32

The project must begin before November 2019 and the maximum duration of a project is 12 months from the date that the sub-granting agreement is signed. The funding is non-dilutive. It must be spent according to Horizon 2020 guidelines. The funding may be used for any activity necessary and relevant to reach the project’s objectives but cannot be used for pure basic research activities.

1.11 European Market Access for Partners (eMAPS) (run by Campus pillar)

➢ Start-ups can register their interest through the EIT Health Optimy platform, starting February.

The Pitch eMAPS (European Market Access for Partners) will contribute to the adoption and diffusion of innovation into healthcare systems by providing expertise and a clear understanding of how, when and who to engage in the innovation process. The programme will also provide specific knowledge about finance and reimbursements schemes of 14 European countries. During 2019, this service will be implemented to be accessible for EIT Health start-ups. Is it for me? eMAPS supports healthcare professionals and health entrepreneurs as well as SMEs.

The Programme Adoption and diffusion of innovation are key for improving healthcare across the EU. eMAPS will contribute by providing insight into key factors that may affect SMEs and entrepreneurs when planning to successfully launch within a country’s health market, as there are specific differences of approach to consider.

It also supports an update to the Healthcare in Europe finance and reimbursement report, providing up-to-date information on 11 EU healthcare systems to further support SMEs and innovators to navigate the health financing and reimbursement landscape.

Objectives ● Spark opportunities for accelerating adoption of innovations that can solve health

challenges in many European countries ● Provide access to innovations by supporting innovators/SMEs from across Europe with

insight to best approach new markets ● Accelerate the pace of economic growth through more successful market penetration ● Help SMEs to leap forward with their businesses due to the adoption of best business

practice and innovative techniques.

Learning Outcomes ● Key factors that affect successful penetration into markets ● Methods that enable assessment of market readiness



33

● Transparency and understanding of health financing and reimbursement systems ● Understanding the principles of how innovation can be adapted to fit different systems

Contact information Official contact: Tracey Marriott,

Director of Clinical Innovation Adoption, Oxford Academic Health Science Network; ([email protected])

Operational contact: Ferdinand Manansala, Programme Coordinator, Oxford Academic Health Science Network; ([email protected])

Start-up contact: Laura Suhlrie ([email protected])

Please see EIT Health Campus Brochure for partners and more information




34

How to join activities in the SCALE! activity line

The SCALE! activity line focuses heavily on developing tools and networks that can provide visibility and financing for projects and small SMEs, as well as facilitating access to potential investors such as angel networks, corporate financers and crowdfunders. Furthermore, GoGlobal programmes will support European start-ups and scale-ups in the domain of Medtech, Biotech and Digital Health so that they can expand in Europe, the United States, Brazil, China and other international markets. The Gold Track programme accepts extremely high-potential start-ups that aim to become global players.

1.12 European Bridgehead Programme ➢ Several application dates apply: The first application deadline is on February 27, 2019.

Following cut-off dates will be announced on the website The Pitch The European Bridgehead programme allows European start-ups and scale-ups individualised internationalisation support. It follows an individual and needs-based approach by matching suitable start-ups suitable SMEs to clusters, accelerators and incubators (CATs) all over Europe. Participating start-ups have the unique opportunity to benefit from physical spaces and services offered by the CATs. It also offers mentoring, services, resources and vacant physical spaces to start-ups that need them. This supports them in creating a soft-landing to enter new markets beyond their home markets. Important Project Dates

• First cut-off: 27 February 2019, 23:59h CET. • Second cut-off: Mid May 2019 (TBD)

Is it for me? This programme targets more mature start-ups aiming to enter new markets. It is open for start-ups of all health-related areas. An incorporation certificate is required for application. In rare circumstances companies that are not incorporated may be eligible. An exception may only be requested after consultation with both the regional Business Creation Manager, and the Programme Manager. Final decisions will then be made centrally. The Programme It is an internationalisation programme for start-ups interested in being hosted by one or several top-notch accelerators/incubators/clusters from the EIT Health European network. Start-ups travel to accelerators of their choice to speed up access to markets, tap into local networks of partners and clients, access infrastructure and get a first-hand feeling for the local regulatory and business context. They are guided by a trusted and seasoned local support team who open the right doors to establish and grow cross-border business.

https://www.eithealth.eu/bridgehead


35

The Funding Participating teams receive vouchers of up to €30k to spend in the programme. Contact information EIT Health Programme Manager: Aina Pascual Cuadras ([email protected]) Partner Contact: Anna Badurska ([email protected]) In cooperation with:

1.13 European Health Catapult ➢ Application deadline: 27 March, 2019.

The Pitch European Health Catapult is a training and competition programme that boosts the development of top-notch European health start-ups. The programme exposes Biotech, Medtech and Digital Health start-ups to high-quality experts and international investors through intensive and multi-channel involvement of the whole EIT Health community. Is it for me? The European Health Catapult is open to micro and small enterprises (<50 employees), spin-offs and start-ups (already incorporated that are looking for a seed or Series A funding of a minimum €500k):

● active in the fields of Medtech, Biotech and Digital Health ● operating in an EU Country ● have innovative business concepts ● connected to the EIT Health community




36

A strong focus will be placed on the innovation’s impact in terms of societal challenges for example: Societal Challenges Business objectives

Promoting healthy living Lifestyle interventions Self-management of health

Supporting active ageing Workplace interventions Overcoming functional loss

Improving healthcare Improving healthcare systems Treating and managing chronic diseases

Important Deadlines? ● Application deadline: 27 March, 2019 ● Regional Stage: April-May 2019 – The best regional start-ups selected in each category:

Medtech, Biotech and Digital Health. ● Semi-Finals: 24-26 September, Delft/Leiden for Biotech; 30 September-2 October, San

Sebastián for Medtech; 8-10 October London for Digital Health ● International centralised training and selection days ● Finals: 2-3 December, 2019 at the EIT Health Summit in Paris

The European Health Catapult follows a three-stage procedure Stage 1: Interested companies apply to participate at the regional level. The seven regional competitions will be organised based on the EIT Health regional structure. Start-up companies may only apply to one region. Companies are advised to apply to the regional office they are most likely to associate with. For instance, companies should self-identify with this region, have their company registered in this region, or have a second office in this region. Please be aware that attendance for local events in person may be required. The pre-selection of the nominated start-ups will be made by each region, based on a common set of criteria. Regions are free to define their individual selection process but are encouraged to run pitch sessions, workshops or other assessments to ensure that the quality of start-ups representing them are outstanding in an international context. The best regional start-ups in each category (Medtech, Biotech and Digital Health) will be identified by June 2019. The selected companies (42 in total, 14 per category) will be presented by their regional representatives during an informal consensus meeting. Stage 2: Centralised training and selection days (semi-finals) will be held for each of the three categories Biotech, Medtech and Digital Health. Those events will occur before 15 October, 2019. Each one of those days will have the following format:


37

● During a two-day semi-final, participating start-ups will be matched with mentors (experienced entrepreneurs, investors, experts in the field) to strengthen and optimise their business plan, and gain intensive pitch training to prepare their ability to perform for top-level investors.

● During a one-day expo immediately following the training and selection days, all participants will pitch to a jury and audience of subject-matter experts and investors. The top seven companies per category will be selected and invited to pitch at the EIT Health Summit 2019.

Stage 3: At the EIT Health Summit, winners will be selected, and prizes awarded by a panel of experts, industry stakeholders and investors (business angels, corporate VCs and crowd funders). Why participate? Entering the European Health Catapult gives participants the opportunity to join a unique forum for innovators with an intensive two-step selection and 360° preparation. This involves dedicated training and selection days that allow participants to optimise their business plan and strengthen their ability to pitch in front of top-level investors and industry stakeholders. Participants gain real-world entrepreneurial experience and potential access to an international network of world-leading Medtech, Biotech, pharma and IT companies that are partners of EIT Health and Health Axis Europe. These include, but are not limited to:

● Siemens Healthineers ● Philipps ● GE Healthcare ● SAP ● Medtronic ● Abbott ● AbbVie ● Roche ● Sanofi ● ThermoFischer Scientific ● Astra Zeneca ● Bayer Pharma ● Merck ● Air Liquide – as well as world-class research organisations in healthcare.

Participants will also have early access to an international network of investors (VCs, corporate VCs, business angels, crowd investors) to boost their business ideas, as well as guidance to access


38

unique services offered by EIT Health networks in crucial areas such as clinical validation (living labs and test beds) and the mentor and expert platform. Prize money and cost coverage Stage 1: In total, 42 teams (14 per category) will be nominated from seven CLCs. These nominees will be invited to a compacted training programme designed to prepare the teams and a selection day with a competition in each category. Benefits include reviewing the business plan, pitch training, and exposure to experts and investors. Selected start-ups in the digital health domain will receive a one year Premium 1Mby1M scholarship. Stage 2: Half of these semi-finalists – a total of 21 teams (seven per category) – will be chosen at the training and selection days and will be invited to pitch at the finals during the EIT Health Summit. Travel costs will be covered. Stage 3: At the EIT Health Summit, the ‘best of the best’ business plans in Medtech, Biotech and Digital Health will be selected by a panel of experts. The top three finalists in these categories will receive an award based on their placing. The maximum amount of all prizes awarded will be €135,000. Application Information ● Applications should be submitted in executive summary format with extraction of key

numbers from the business plan if any. A video pitch is highly welcome. ● Late or incomplete submissions, or submissions via any other routes (e.g., email) will not be

accepted. ● Important note: Applicants are only allowed to participate in either the EHC or Headstart

Programme. ● Applicants in the digital health domain will receive a 3 months 1Mby1M Basic scholarship How do we evaluate? Eligibility criteria ● Follow the timelines and procedures (for digital health start-ups registration for the 3 months

Basic scholarship is mandatory) ● Submitted by a micro and small enterprise (with fewer than 50 employees) Selection criteria ● Uniqueness and innovative nature of the approach ● Clearly identified product or service ● Market potential ● Major market risks and technical risks identified and evaluated


39

● Feasibility of the deployment plan ● Qualified team with the capacity to bring the innovation to market ● Impact on societal challenges addressed by EIT Health. Review process Each proposal in Stage 1 is reviewed by the respective region on the basis of the common selection criteria. The applicants will be informed about their score and ranking. Each region nominates the best two proposals per category (Medtech, Biotech, Digital Health) for Stage 2 to attend the centralised international training and selection days in their respective category. Contact information: Activity Leader: Anna Badurska, European Project Manager, Cap Digital ([email protected]) Second contact point: Marco Wendel, Grants Consultant & Project Management, Medical Valley EMN ([email protected])


1.14 Investor Network ➢ Applications will be accepted on a regular basis, with four calls during the year

The Pitch This Investor Network addresses the issue of early-to-late-development stage fundraising across Europe to conquer health markets faster and better. This network connects health-oriented investors and promising start-ups through cross-border financing and co-investments, making it the first pan-European, EU-driven network solely focused on financing health innovation. Important Project Dates There are four calls during the year to attract start-ups: Early January, early March, end of July and early October. Is it for me? Start-ups must be registered and at minimum seed stage with public grants and have money already raised to a significant level. The Programme


about:blank

about:blank


40

The programme connects start-ups to investors to allow them to access funds for Seed to Series C rounds, by it is a unique networking programme that displays the start-up’s funding needs to a variety of investors, including private equity investors. It is also the first programme of its kind in Europe to offer a continuum of investment. It has the ambition to leverage investment by creating a close-knit network of healthcare investors that know and trust each other, and who share the same ambition of bringing smart money to innovative European start-ups. The Investor Network journey for start-ups starts with an application through the EIT Health Optimy platform. Upon approval by the BCM, start-ups are invited to sign a Memorandum of Understanding which will give them access to a deal flow management platform where they will upload their documents for review by our selected investors. Investors will contact them if interested to ask for their information and potentially begin a due diligence check. They will be invited to pitch via WebEx or in person, then proceed with individual negotiations. The Investor Network collaborates closely with other investment programmes within EIT Health such as the Crowdfunding Platform. Contact information Activity leader: Caroline Sai ([email protected]) In cooperation with:

1.15 GoGlobal ➢ Applications are open between 11 January and 27 March

Europe is home to many life science companies, the majority of which employ fewer than 50 people. New companies can find it difficult to grow, especially when introducing new treatments or complex technologies to established markets. GoGlobal aims to provide your company with the competence needed for growth and international expansion, remain competitive worldwide, and to build up business contacts in new regions. To succeed internationally, your company needs a comprehensive understanding of various markets and their specific requirements as they relate to healthcare systems, regulatory and reimbursement systems, and how your product influences the business case in the foreign life science market. The GoGlobal programme helps you understand the local ecosystem (trends, best practices, key stakeholders, competitors), the specificities of the markets, and how to





41

succeed in making your business international. GoGlobal also offers strong networking opportunities and access to local support stakeholders for faster success and long-term follow-up. Value: The commercial value of these programmes is an estimated €10,000, and no equity is asked for in return. Travel costs can be partly reimbursed by EIT Health. Our Offer: Soft-landing with market-entry support and experience targeting the following countries: China: particularly receptive to new science and technology in both Hong Kong and Shenzhen. Developing into the second-largest healthcare market, the business environment is not easy to handle for foreigners. Hong Kong offers an ideal infrastructure for international companies that want to enter the Asian market. Mainland China, more specifically the highly innovative Shenzhen region, is a quickly growing market that is suitable for scaling innovations. Canada: particularly receptive to Medtech and Digital Health. Gain access to the complementary ecosystems of Toronto and Montreal. A thrilling alternative to the US to access the North American market. Unique agreement with Europe to fund innovative collaborations, and new trade agreements. Japan and South Korea: Gain access to these complex markets by tapping into existing successful networks and trustful business relations set up by mature cluster managers with established global networks. Why participate? Within the programmes you will have the opportunity on-site to develop an internationalisation strategy for your business, and answer questions like:

● What are the specific regulatory affairs? ● Which hurdles am I facing in my specific market? ● Which partners do I need and how can I find them in my region? ● Who can help with this within the local environment? When you finish the programme, you will have the knowledge and local contacts you need to successfully enter your target country. With the EIT Health GoGlobal programmes, you will have the opportunity to learn directly from experienced companies and experts who have already answered these questions. You will benefit from preparatory workshops to get the highest added value possible and get country-specific know-how (cultural and business) in the target market you wish to enter. Is it for me? The target participant profile in the GoGlobal programmes are start-ups, scale-ups or SMEs. They must either:


42

1. Possess a product and have started to sell, 2. Have strong proof of concept, advanced in the regulatory/certification process, and have the

ambition to expand to the international market within the next 12 months.*

*No requirements are made on the sales–to-date, but proof should be provided that the product/technology/service works and that customers are willing to pay for it or that key opinion leaders and partners are supporting it.

The company should fit the overall EIT Health thematic scope: “Healthy Living, Active Ageing, Improved Health Care.” Any suitable company in the areas covered by the EIT Health CLCs can apply. What target country should I choose? The GoGlobal Consortia would like to support you in choosing the best programme for your company to individualise your experience. When applying online you will be asked to indicate: 1) the country you would like to target 2) the category you are active in (Medtech, Biotech, Digital Health) and 3) which programme you believe best matches your maturity and interests. You may be contacted and asked for additional application information if we believe your company is more suited to a different programme than you initially indicated due to maturity or focus. If you are at the beginning of your internationalisation plans and aim to explore your market opportunities as well as identify your strategy, the GoGlobal Medtech/Digital Health programme led by Sting might suit your needs best. This programme provides insight into different global markets of interest to enable you to decide on the best internationalisation location for your business. Submission of Application Applications open from 11 January via the EIT Health Optimy platform. Deadline for submissions: 27 March Programme Timeline and Specifics GoGlobal Canada The Pitch GoGlobal CANADA programme will provide 13 top European SMEs with a unique gateway to three recognised hubs of innovation in Canada, and a major stepping stone towards the North America market. Reciprocity will be a key added value of the programme, with long-term involvement of strong local partners developed at recognised international events. Is it for me? Participants should fulfil the following criteria:

- Strong existing traction in Europe / international partnerships


43

- MVP and/or first clinical data to be obtained before September 2019 - For medical devices, CE mark obtained or expected by the end of 2019 - Existing revenues for Digital Health companies

This programme aims to attract innovative healthcare SMEs (biopharma / Medtech / Digital Health). Preferred areas of focus include AI, diagnostics, genomics, Medtech and e-health.

Timeline

● 27 March: Application deadline ● April: Selection process ● May: Information webinar on Montreal, Toronto & Vancouver ● 25-26 June: Preparatory workshops / Canadian delegation during MEDFIT event (Lille) ● September – November: Immersion programme in Canada (final date depends on selected

companies' needs and potential synergies with local partners) ● 11-14 November: Internationalisation workshop / Canadian delegation at MEDICA fair

(Dusseldorf) ● End of 2019/early 2020: An Individual follow-up with each SME

The Programme: It starts with individual meetings to better understand and qualify the SME’s needs and expectations of the programme. It will be followed by a high-level webinar to present the specificities and local players of the three ecosystems. Preparatory workshops during the MEDFIT event on Canadian market access, and the possibility to network with Canadian delegation will also be part of the programme. Additional on-site programmes take place in Canada during the second semester. Additional visibility, networking and sharing experience between peers during MEDICA event will be provided in mid-November. Each SME will benefit form a 2000€ travel voucher.

The immersion programme to Canada offers the following assets:

● B2B Meetings with qualified key stakeholders including support structures, KOLs, and potential partners

● On-site visits to key R&D sites, incubators and accelerators ● Introduction to VC firms and potential roadshow ● High-level visibility towards the local ecosystem (e.g. pitch and networking events in each

ecosystem) ● The goal of the programme is to develop a high level of understanding of the local business

environment, regulatory framework and innovation ecosystem. Moreover, a company market strategy will be defined enabling access to the Canadian and North American market. Also, commercial and partnership opportunities will be validated.

Contact information: Official contact: Olivier Fontaine ([email protected])



44

News and updates:

• Communication articles through the EIT Health website • LinkedIN • Twitter #GoGlobal#Canada#EITHEALTH (account @ofontaine89)


GoGlobal Medtech Exchange Accelerator The Pitch Starting with a workshop in the Nuremberg (Germany) area and concluding in autumn with a one-week immersion journey to China, this programme will give you first-hand insights about the country specifics of the healthcare market, as well as any major pitfalls and solid contacts to foster your business. The programme is a proven concept and has been running for the last three years and has many trusted partners.

Is it for me? We are looking for start-ups and SMEs in the area of Medtech, Digital Health and life sciences. Sales and/or market readiness in your home country is required. Also, an existing CE mark is a major milestone. Any prior experience from EIT Health Bootcamps, the Business Plan Competition, the Investors' Network, the European Health Catapult or other GoGlobal programmes is helpful.

Timeline

● 20 May: Inbound (up to 5 days) and Outbound (up to 3 days) Preparation Workshop in Erlangen/ Nuremberg

● October/November: Journey to China / Hong Kong The Programme: Starting with a workshop in the Nuremberg area and concluding in autumn with a one-week immersion journey to China the programme will give you the opportunity to gain first-hand insights about the country specifics of the healthcare market and major traps. Our Outbound Journey will be implemented through major events with our partners overseas (e.g. Sky 100 Elevator Pitch competition in Hong Kong) so you can get high visibly while you learn about your target country. Each team will receive around 10.000€ in commercial total value.


45

The goal of the programme is to gain insights on CFDA, to learn about foreign country business specifics, experience the culture and network. Companies will learn about the challenges of the Chinese market and how to tackle them.

Contact information: Official contact: Benjamin Stöcklein ([email protected]) In cooperation with:

GoGlobal Start.Smart.Global - Accelerating market entry in Japan and South Korea for European Life Science SMEs The Pitch Start.Smart.Global is a high-quality training course providing starter kits for European life science SMEs to optimise their market entries. The training is sector-specific and targets the lucrative but challenging business environments of Japan or South Korea. Participants can select either Japan or South Korea and benefit from workshops, e-learning, webinars, peer training and a roadshow in their target country. Project outputs include individual market entry strategies, valuable contacts, and a realistic evaluation of market potentials.

Is it for me? Start.Smart.Global is for innovative healthcare SMEs in Biopharma/Medtech or Digital Health. Preferred areas of focus will be therapeutics, diagnostics, genomics, Medtech and e-health. We are looking for mature start-ups and scale-up SMEs that are new to the target country. Start.Smart.Global is a modern, high quality training course tailored to the demands and time constraints of SME managers. Participants benefit from a year-long e-learning tools, webinars, telcos, peer training and a roadshow to their target country. The training is demand-driven and user-friendly. Project outputs are individual market entry strategies, valuable new contacts, and a realistic evaluation of market potentials.

Haven taken part in prior EIT Health entrepreneurial trainings, Bootcamps, Product Market Fit, European Health Catapult is helpful.

Timeline

● 27 March: Application deadline

● 1-5 July: On-site training in South Korea (in Paris, France) ● 9-13 September: On-site training in Japan (in Munich, Germany)



46

● 7-10 October: Roadshow in South Korea (around the time of the BIOplus conference in Seoul)

The Programme: Start.Smart.Global taps into existing successful networks and trustful business relations set up by mature cluster managers with established global networks. Building on experiences from Start.Smart.Japan (GoGlobal 2018), the project expands its scope and focuses on Japan and South Korea. Korea represents a new challenging market, where clusters can make a difference in their SME’s success. The cluster partners BioM (lead), Medicen, and Biocat bring in complementary expertise and provide excellence in SME training, offering networks in biopharma, medical devices, and e-health.

Start.Smart.Global aims to act as a best-practice service model for other clusters, contributing to the global recognition of innovative SMEs and strengthening Europe’s position in the global health sector. Building up the strength of EU innovators makes them globally competitive in the market, and attractive as partners for pharma and global R&D collaborations. Participants will become future peers, with the potential to train and positively influence regional networks and help them mature. Successful applicants will receive a prize money of 2.500€ after full participation in the programme.

At the end of the programme, there will be a best practice training course concept for other life science cluster and ecosystem managers. More information will be revealed in early 2020.

Contact information: Official contact: Stephanie Wehnelt ([email protected]) News and updates:

• Website: to be announcedTwitter: @BioM_Munich; @biocat_cat; @Pole_Medicen • LinkedIN, Facebook, vimeo


GoGlobal Medtech / Digital Health

The Pitch



47

The uniqueness of this programme is that every session will be hosted by a successful Medtech company with extensive experience to share. The programme targets Medtech and Digital Health companies that are searching for their first exporting market. Five sessions of two days each cover Europe, the US and China.

Is it for me? The programme targets Medtech and Digital Health companies that are hoping to identify their ideal internationalisation location. Ideally, they have launched or are about to launch their product in their home market and now are ready to start exporting within 12 months. Participating projects should be CE approved and product/services launched in home markets.

Timeline

● 27 March: Application deadline

● 15-30 March: Selection of companies

● 1-5 April: Participants are informed

● 15-16 May: Session 1 in Stockholm

● 12-13 June: Session 2 (location TBD)

● 11-12 September: Session 3 (location TBD)

● 2-3 October: Session 4 in Madrid

● 13-14 November: Session 5 in Stockholm

The Programme: The programme focuses on start-ups that are looking to identify the ideal international market for their businesses and will support you to first focus your current business offer and second explore the possibilities in the US, China and Japan. The programme consists of five sessions of two days each (10 days in total). The first session focuses on challenging participants on go-to-market strategy and value proposition. Companies should also set up a clear goal for the programme, which will then be followed up. The second session focuses on the European area since this is normally the first export market for start-ups. The third session focuses on the US market. The fourth session focuses on China and Japan. The fifth and last session focuses on financing for internationalisation, exploring how to fund your export into other countries. During the second day of this session, the companies will present their plan for internationalisation to an expert panel and receive feedback that they can discuss within their management or board. A winner will be selected by the panel based on the best-elaborated plan.

The uniqueness of the programme is that every session will be hosted by a successful Medtech company with lots of experience to share. The participants can ask questions and discuss


48

important topics with the hosting company so they can expand their learning. In best cases, the hosting companies might find an interesting company among the participants that they would like to continue talking to about a potential partnership/cooperation.

The participating companies will receive an enormous amount of knowledge and experiences during the programme that they would not receive anywhere else. The best available experts will come to them during the programme. They will also get a lot of valid contacts, both from the speakers but also from the hosting Medtech companies. With the funding of EIT Health and the reimbursement of travel costs, this programme offers great value for money which is very competitive.

Please find in the following an overview of the content of each session

• SESSION 1: PREPARE FOR EXPORT, 15-16 MAY, STHLM Lean canvas presentation, export ambitions, goal and expectations with program, NABC pitch etc.

• SESSION 2: EUROPE, 12-13 JUNE, TBD Healthcare systems in Europe, Britain, Germany and France, reimbursement, regulatory, sales, distribution and establishing a business in Europe

• SESSION 3: USA, 11-12 SEPTEMBER, TBD The US healthcare system, insurance system, FDA, reimbursement, legal system, CMS, CPT coding

• SESSION 4: ASIA MARKETS, 2-3 OCTOBER, MADRID Healthcare systems in Japan and China, regulatory, reimbursement, distribution sales and establishing a business

• SESSION 5: FINANCING FOR INTL GROWTH & FINAL PRESENTATION, 13-14 NOVEMBER, STOCKHOLM

How to finance and organize your company for internationalization and rapid growth. Each participating company makes a presentation of its internationalization strategy to a panel of experienced persons from Medtech companies.

Contact information: Official Contact: Olof Berglund ([email protected]) In cooperation with:



49

Selection criteria of all GoGlobal Programmes: ● Fit between the company and the programme:

o Collaborations/sales in the home market o Active plans for internationalisation within approximately one year o Commitment from company management o Ability to actively participate in the programme o Financial capacities

● Fit with EIT Health thematic scope and contribution to EIT Health objectives and KPIs ● Fit into target country life science environment ● Business potential and market traction:

o Current market position o Growth and diversification potential of the company o International market potential of the product, process or service / existing references in

the targeted market(s) Review process: The selection committee will assess applications based on the criteria outlined above.

1.16 Gold Track The Pitch The Gold Track is an intense tailor-made scaling programme that offers hands-on individual guidance to elite start-ups. Gold Track takes a global approach and provides promising start-ups and SMEs a deep dive assessment, an individualised roadmap built by their personal high-level advisor, implementation support and access to network resources and programmes. This work will enable them to make advances in their internationalisation efforts. Is it for me? Start-ups in the scale-up phase that show promise of future high performance will excel in the Gold Track. Participating start-ups will be scouted and/or nominated by the local Business Creation Managers and selected by an independent panel of experts of high standing and recognisability. The Programme The Gold Track will allow for high-potential start-ups to be supported with resources such as access to programmes, mentoring and a grant to achieve immediate project goals. It offers outcome-oriented advisory support for selected companies seeking growth in international markets. These start-ups will be fully assimilated into the EIT Health network. They will be allocated resources from the EIT Health portfolio, from collaborating partners and from external sources. Their one-year journey will be supervised by a senior mentor from the selection


50

committee that will provide networking opportunities and advice and set high-level strategic goals. Contact information: Official contact: Joy Cürten ([email protected]) In cooperation with the EIT Health community



51

Annex:

Sustainability vision Since 2016, the EIT Health Accelerator has offered its programmes as complimentary based on structured selection processes to determine company valuation and merit. It does not ask for any contribution in return. In order to continue to support start-ups and the European economy, in the future EIT Health may ask awarding companies to contribute commitment fees or share in the companies’ economic success. If EIT Health makes amendments to its current complimentary structure, participating companies will be informed in a timely manner and prior to signature.

Understanding TRL Special thanks to KTH Innovation for providing these images.


52

TRL according to EU


53


54

Understanding HIR The table below serves as orientation to define your HIR level. Comprehensive background information about the HIR tool can be found here. Applicants should achieve at least level 3 among all dimensions. It Is aimed that after receiving the grant, at least level 4 among all dimensions is reached. Please note, if applicants consider the HIR tool as not suitable to assess the innovation readiness level we recommend to refer to the TRL. Therefore, applicants should fit at least into TRL 4 (please find detailed information here).

https://cimit.org/documents/173804/228699/Navigating+the+HealthTech+Innovation+Cycle.pdf/2257c90b-d90b-3b78-6dc9-745db401fbc6?version=1.0

https://www.wmahsn.org/storage/resources/documents/EIT_Health_KIC_A_guide_to_TRL-EIT_health.pdf


55

Documents

EIT Health Accelerator · THE EIT HEALTH ACCELERATOR ... impact on both the pharmaceutical industry and patients to tackle challenges set by top pharma partners. ive challenges have